IL-8 and cancer prognosis on immunotherapy
Nat Med
.
2020 May;26(5):650-651.
doi: 10.1038/s41591-020-0873-9.
Authors
Ziad Bakouny
1
,
Toni K Choueiri
2
Affiliations
1
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
2
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. toni_choueiri@dfci.harvard.edu.
PMID:
32405061
DOI:
10.1038/s41591-020-0873-9
No abstract available
Publication types
Comment
MeSH terms
Humans
Immunologic Factors
Immunotherapy
Interleukin-8*
Neoplasms*
Neutrophils
Substances
Immunologic Factors
Interleukin-8